Imiquimod, an imidazoquinoline amine, is an immune response modifier recently approved
for the topical treatment of external genital and perianal warts. Although the majority of …

Imiquimod, the first member of a new class of immune response modifiers, is approved for
the treatment of external genital and perianal warts. The clinical effect of imiquimod stems …

Imiquimod, an imidazoquinoline amine, is an immune response modifier first FDA-approved
for the treatment of external genital and perianal warts in 1997. Since its appearance on the …

Imiquimod is a synthetic imidazoquinoline heterocyclic amine of 240.3 Da (C14H16N4).
Imiquimod is a cytokine inducer and a modifier of the innate immune response, as well as …

Background: Genital warts are a common sexually transmitted disease caused by human
papillomavirus. Imiquimod is a novel immune-response modifier capable of inducing a …

Imiquimod: A cytokine inducer - ScienceDirect Skip to main contentSkip to article Elsevier logo
Journals & Books Search RegisterSign in View PDF Download full issue Search ScienceDirect …

Imiquimod is an immune response modifier that stimulates the patient's own immune system
to release various chemical substances, such as interferon and interleukin-12. Although …

A central development of the past decade has been in our understanding of the interactions
between, and interdependence of, the innate and adaptive immune responses. Innate …

Imiquimod (S-26308, R-837)(1-(2-methylpropyl)-1H-imidazo [4, 5-c] quinolin-4 amine), an
immune response modifier, demonstrates potent antiviral and antitumor activity in animal …

ALDARA (imiquimod cream 5%) recently became available for the treatment of genital and
perianal warts; however, the topical mechanism of action of imiquimod is not fully …